The vector of anti-IL13Rα2 chimeric antigen receptor (CAR) is a ligand-based CAR constructed for the engineering of T cells to target human IL13Rα2. The T cells are genetically modified through transduction with a retroviral vector expressing protein of IL13(E13Y) linked to CD3ζ signaling domain. And the vector product was designed for the treatment of glioblastoma multiforme.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-ZP075||Anti-IL13Rα2 (Hu07H2L) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-ZP076||Anti-IL13Rα2 (Hu07H2L) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-LC284||Anti-IL13Rα2 h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1|
|CAR-LC287||Anti-IL13Rα2 h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1|
|CAR-ZP077||Anti-IL13Rα2 (Hu08H2L) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-LC235||Anti-IL13Rα2 (m47) h(-CD28-CD3ζ) CAR, pCDCAR1|
|CAR-LC236||Anti-IL13Rα2 (m47) h(CD28-41BB-CD3ζ) CAR, pCDCAR1|
|CAR-ZP078||Anti-IL13Rα2 (Hu08H2L) h(CD28-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved